Knowledge, Perceptions, and Practice of Nurses on Surveillance of Adverse Events following Childhood Immunization in Nairobi, Kenya
Table 4
Practice level of respondents towards AEFI surveillance.
Practice aspects
Yes, (%)
No, (%)
Ruling out contraindications to vaccine(s) in a child prior to administration
230 (83.9)
44 (16.1)
Having an anaphylactic pack with adrenaline in the immunization room
39 (14.2)
224 (85.8)
Informing the caretaker of possible vaccine adverse reactions and how to treat them
155 (56.5)
119 (43.5)
Having ever come across a child with injection site swelling, redness, abscesses, BCG lymphadenitis, convulsion, shock, AFP, or fever > 40°C and diagnosing it as an AEFI
88 (32.1)
186 (67.9)
Reporting detecting an adverse event following immunization
2 (2.3)
86 (97.7)
Participating in AEFI investigation for detected AEFI cases
2 (2.3)
86 (97.7)
Recording vaccine batch number and expiry date during vaccination
209 (76.3)
65 (23.7)
Having ever seen an AEFI reporting and investigation form
122 (44.5)
152 (55.5)
Having AEFI reference guidelines materials at workstation
106 (38.7)
168 (61.3)
Having relevant AEFI specimen transportation containers
69 (25.2)
205 (74.8)
Total sample size, . Data are presented as number of subjects and proportions (%). AEFI: adverse event following immunization; BCG: Bacillus Calmette–Guérin.
